Jnci-journal Of The National Cancer Institute

SCI SCIE

国际简称：J NATL CANCER I 参考译名：美国国家癌症研究所Jnci杂志

主要研究方向：ONCOLOGY 非预警期刊审稿周期：偏慢,4-8周

《美国国家癌症研究所Jnci杂志》(Jnci-journal Of The National Cancer Institute)是一本由Oxford University Press出版的以ONCOLOGY为研究特色的国际期刊，发表该领域相关的原创研究文章、评论文章和综述文章，及时报道该领域相关理论、实践和应用学科的最新发现，旨在促进该学科领域科学信息的快速交流。该期刊是一本未开放期刊，近三年没有被列入预警名单。该期刊享有很高的科学声誉，影响因子不断增加，发行量也同样高。

1区中科院分区
Q1 JCR分区
220 年发文量
7.7 IF影响因子
未开放 是否OA
333 H-index
1940 创刊年份
Semimonthly 出版周期
English 出版语言

The Journal of the National Cancer Institute publishes peer-reviewed original research from around the world and is internationally acclaimed as the source for the most up-to-date news and information from the rapidly changing fields of cancer research and treatment. For the past several years, the JNCI has been ranked as one of the most-cited original-research cancer journals by the Institute of Scientific Information in its annual Journal Citation Reports.

[ 查看全部 ]

投稿咨询加急咨询

Jnci-journal Of The National Cancer Institute期刊信息

ISSN：0027-8874
出版语言：English
是否OA：未开放
E-ISSN：1460-2105
出版地区：UNITED STATES
是否预警：否
出版商：Oxford University Press
出版周期：Semimonthly
创刊时间：1940
开源占比：0.2626
Gold OA文章占比：35.29%
OA被引用占比：0.2637...
出版国人文章占比：0.03
出版撤稿占比：0
研究类文章占比：98.18%

Jnci-journal Of The National Cancer Institute CiteScore评价数据（2026年6月最新版）

CiteScore

SJR

SNIP

CiteScore 指数

12.3

3.786

2.512

学科类别	分区	排名	百分位
大类：Medicine 小类：Oncology	Q1	40 / 428	90%
大类：Medicine 小类：Cancer Research	Q1	33 / 233	86%

名词解释：CiteScore 是衡量期刊所发表文献的平均受引用次数，是在 Scopus 中衡量期刊影响力的另一个指标。当年CiteScore 的计算依据是期刊最近4年（含计算年度）的被引次数除以该期刊近四年发表的文献数。例如，2022年的 CiteScore 计算方法为：2022年的 CiteScore =2019-2022年收到的对2019-2022年发表的文件的引用数量÷2019-2022年发布的文献数量注：文献类型包括：文章、评论、会议论文、书籍章节和数据论文。

Jnci-journal Of The National Cancer Institute中科院评价数据

《新锐期刊分区表》（2026年3月发布）

Top期刊	综述期刊	大类学科		小类学科
是	否	医学	1区	ONCOLOGY 肿瘤学	1区

Jnci-journal Of The National Cancer Institute JCR评价数据

2025-2026年最新版

按JCI指标学科分区	收录子集	分区	排名	百分位
学科：ONCOLOGY	SCIE	Q1	49 / 333	85.4
学科：ONCOLOGY	SCIE	Q1	43 / 333	87.24

Jnci-journal Of The National Cancer Institute历年数据统计

影响因子

中科院分区

Jnci-journal Of The National Cancer Institute中国学者发文选摘

1、Electro-acupuncture for quality of life during adjuvant chemotherapy in gastric cancer: a randomized tria
Author: Zhu, Yan-Juan; Chang, Xue-Song; Wu, Xiao-Yu; Wang, Wei; Diao, De-Chang; Li, Yong; Zhang, Hong-Yu; Xiao, Jian; Zhai, Xiao-Hui; Yu, Jin-Long; Zhou, Jing-Xu; Huang, Zhi-Liang; Zhang, Tao; Ouyang, Wenwei; Janjigian, Yelena Y.; Cytryn, Samuel L.; Xiao, Zhen-Zhen; Liu, Yi-Hong; Zhou, Rui; Ma, Hao-Chuan; Chen, Ya-Dong; Peng, Jian-Jun; Mao, Jun J.; Zhang, Hai-Bo

Journal: JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE. 2026; Vol. 118, Issue 4, pp. 603-612. DOI: 10.1093/jnci/djaf309
2、Prediagnostic dietary phytosterol intake, inflammatory biomarkers, and colorectal cancer survival: a cohort stud
Author: Wu, Tiantian; Ou, Qingjian; Xu, Huan; Chen, Yuanyuan; Lin, Fangting; Fang, Yujing; Zhang, Caixia

Journal: JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE. 2026; Vol. , Issue , pp. -. DOI: 10.1093/jnci/djaf325
3、RE: Electroacupuncture for quality of life during adjuvant chemotherapy in gastric cancer: a randomized tria
Author: Sun, Man; Zang, Dan; Chen, Jun

Journal: JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE. 2026; Vol. , Issue , pp. -. DOI: 10.1093/jnci/djag012
4、Response to Sun, Zang, and Che
Author: Chang, Xue-Song; Zhu, Yan-Juan; Mao, Jun J.; Zhang, Hai-Bo

Journal: JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE. 2026; Vol. , Issue , pp. -. DOI: 10.1093/jnci/djag013
5、Sex steroid hormones, gonadotropins, and risk of testicular germ cell tumors: results from the STEED stud
Author: Wu, Zeni; Wojt, Aika; Trabert, Britton; Almeida, Andrea A.; Rifai, Nader; Stanczyk, Frank Z.; Graubard, Barry, I; McGlynn, Katherine A

Journal: JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE. 2026; Vol. , Issue , pp. -. DOI: 10.1093/jnci/djaf376
6、RE: a prediction model for metachronous colorectal cancer: development and validatio
Author: Yu, Zekai

Journal: JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE. 2026; Vol. , Issue , pp. -. DOI: 10.1093/jnci/djaf351
7、Conditional recurrence-free survival after curative esophagectomy: individual patient data analysis of 11 trial
Author: Okui, Jun; Matsuda, Satoru; Nagashima, Kengo; Sato, Yasunori; Kawakubo, Hirofumi; Ruhstaller, Thomas; Thuss-Patience, Peter; Nilsson, Magnus; Klevebro, Fredrik; Tan, Lijie; Zhang, Shaoyuan; Aparicio, Thomas; Piessen, Guillaume; Van Der Zijden, Charlene; Mostert, Bianca; Wijnhoven, Bas P. L.; Tsushima, Takahiro; Takeuchi, Hiroya; Kato, Ken; Kitagawa, Yuko

Journal: JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE. 2026; Vol. , Issue , pp. -. DOI: 10.1093/jnci/djaf347
8、Dynamic ctDNA informs whole-course postoperative precise management of NSCLC (LUNGCA study
Author: Xia, Liang; Pu, Qiang; Kang, Ran; Mei, Jiandong; Li, Lu; Yang, Ying; Deng, Senyi; Feng, Gang; Deng, Yulan; Gan, Fanyi; Lin, Yidan; Ma, Lin; Lin, Feng; Yuan, Yong; Hu, Yang; Guo, Chenglin; Liao, Hu; Liu, Chengwu; Zhu, Yunke; Wang, Wenping; Liu, Zheng; Xu, Yuyang; Li, Kaidi; Li, Chuan; Chen, Weizhi; Li, Qingyun; Du, Bo; Zhang, Xiaolong; Kou, Yingli; Wang, Yun; Wu, Zhu; Che, Guowei; Chen, Yaohui; Shen, Shensi; Chen, Longqi; Xie, Dan; Liu, Lunxu

Journal: JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE. 2025; Vol. , Issue , pp. -. DOI: 10.1093/jnci/djaf061